Delivery Order SPE2DB22D1202-SPE2DB25FUZA3
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,183.44 firm fixed-price contract is for the supply of XHANCE 93 MCG Nasal Spray 16ML, with a completion date of November 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.80, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.95, is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 26, 2025. The contract is not designated as a set-aside and was open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XHANCE 93 MCG Nasal Spray, a pharmaceutical product, with a ceiling value of $1,212.30 and a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,280.16, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,086.89 firm-fixed-price delivery order is for the supply of XHANCE 93 MCG Nasal Spray 16ML, with a period of performance through August 23, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a Firm Fixed Price pricing type and a ceiling value of $3,283.58. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 25, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, under a Firm Fixed Price delivery order. The contract has a ceiling value of $1,690.88 and a completion date of December 18, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,467.65, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of June 25, 2024. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,600.73 contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML to support federal healthcare programs. The award is not associated with a set-aside program and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...